A NEW WAY OF INITIATING TREATMENT IN HYPERTENSIVE PATIENTS
Chairpersons: A.F. Dominiczak (Glasgow, United Kingdom), G. Parati (Milan, Italy)
- Introduction
A.F. Dominiczak (Glasgow, United Kingdom) - Does first-line monotherapy of hypertension still make sense?
G.L. Bakris (Chicago, USA) - Initiating treatment of hypertension with a novel combination: the outcome of years of research
J.J. Mourad (Bobigny, France) - New combination therapy: a step beyond in terms of blood pressure control
G. Parati (Milan, Italy) - Conclusion
G. Parati (Milan, Italy)
Thanks to
OPTIMAL BP CONTROL: THE LATEST ARB
Session 1. Why Focus on ABPM?
Chairperson: B.H. Oh (Seoul, South Korea)
- Ambulatory blood pressure monitoring in the management of hypertension. A European perspective
Parati (Milan, Italy) - ABPM study results of the latest ARB
H.Y. Lee (Seoul, South Korea)
Session 2. Achieving the Goal
Chairperson: C.H. Kim (Seoul, South Korea)
- Fimasartan in Mexican patients (FIRME Study)
Cardona Muñoz (Guadalajara, Mexico) - The Efficacy and safety of fixed dose combination therapy for treatment of hypertension
Park (Seoul, South Korea)
Thanks to
